Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 32 out of 100. Health systems and care delivery

Topic: Risk, prevention and care in population studies

The Dementia Datahub (https://dementiadatahub.org/) currently provides mapping, data reporting dashboards, system documentation, and public use files (available upon request) of statistics from the year 2020. Available statistics include prevalence and incidence of diagnosed dementia, as well as mortality and COVID-19 infections among prevalent dementia cases and all average all cause expenditures among prevalent dementia cases in fee-for-service Medicare. All estimates are available at the national, state, and county level, overall and within subgroups defined by age group, sex, race/ethnicity, and FFS/MA enrollment status. The tool additionally allows for bi-variate analyses and overlay with state or county-level measures of demographics, poverty and education levels, vision or hearing impairment, number of physicians per capita, and FFS/MA enrollment rates. This year we will add 2021 data and additional outcome measures of hospitalizations and long stay nursing home placement among prevalent dementia cases. If funding can be obtained, goals include expansion to add additional years of data, additional capabilities, and updating closer to real-time. The Dementia DataHub provides an important resource to government, academic, industry, advocacy, and medical organizations working to address the epidemic of cognitive impairment and dementia.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Power, M. C., Gianattasio, K. Z., Jason, W., Murphy, R. A., Hartzman, A., Montazer, J. S., et al. (2025). Introduction of an open‐access national‐level U.S. dementia surveillance system. Alzheimer s & Dementia. https://doi.org/10.1002/alz70860_100503

Vancouver

Power MC, Gianattasio KZ, Jason W, Murphy RA, Hartzman A, Montazer JS, et al. Introduction of an open‐access national‐level U.S. dementia surveillance system. Alzheimer s & Dementia. 2025. doi:10.1002/alz70860_100503. PMID: 41434796.

BibTeX

@article{power2025-41434796,
  author  = {Power, Melinda C. and Gianattasio, Kan Z. and Jason, Wachsmuth and Murphy, Ryan Anne and Hartzman, Alex and Montazer, Jaleh S. and Cutroneo, Erin and Wittenborn, John S. and others},
  title   = {{Introduction of an open‐access national‐level U.S. dementia surveillance system}},
  journal = {Alzheimer s \& Dementia},
  year    = {2025},
  doi     = {10.1002/alz70860_100503},
  pmid    = {41434796},
  url     = {https://doi.org/10.1002/alz70860_100503}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.

Key findings

Why it matters

The Dementia DataHub is a public surveillance resource offering 2020 statistics on diagnosed dementia prevalence, incidence, mortality, COVID-19 infections and Medicare expenditures at national, state and county levels. It is a data tool for organizations working on dementia, not a study of any treatment, cure or prevention.

Study details

How this study scored 32/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 2 of 4; Study design 0 of 12; Strength of evidence 1 of 5; Peer-review validation 10 of 10; How recent 4 of 5; Sample size 0 of 4; Effect reported 0 of 3; Studied in people 0 of 3; Randomized / blinded 0 of 2; Times cited 0 of 7; Citations per year 0 of 5; Impact for its field and year 0 of 6; Cited by studies here 0 of 6; Still being cited 0 of 4; Senior author's track record 2 of 4; Institution's track record 1 of 3; Multicenter collaboration 1 of 3; Indexed in PubMed 2 of 2; Free to read 2 of 2. Total 32 of 100.32 of 100 points earned68 not earned

Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Alzheimer s & Dementia)
Journal's citation record 2 / 4 Alzheimer s & Dementia: journal h-index 228 (OpenAlex, 2026-10-29)
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 4 / 5 2025 — within 3 year(s) of the newest study here
Sample size 0 / 4 Participant count not stated — scores zero (not stated in the record — scored 0)
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 0 / 3 Not stated whether this was studied in people — scores zero (not stated in the record — scored 0)
Randomized / blinded 0 / 2 No randomization or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 0 / 7 Cited 0 times (OpenAlex, 2026-10-10)
Citations per year 0 / 5 0.0 citations a year over 3 year(s) since 2025
Impact for its field and year 0 / 6 Cited 0.0× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 0 / 4 Cited 0 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 2 / 4 Last-listed author David B. Rein: h-index 35 (OpenAlex, whole career)
Institution's track record 1 / 3 George Washington University: institution h-index 881 (OpenAlex)
Multicenter collaboration 1 / 3 OpenAlex lists 2 institution(s) in 1 country
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 41434796)
Free to read 2 / 2 Free to read
Total 32 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Studies in the library that share something with this one. The line above each title says what.

Related studies in Health systems and care delivery

Also tagged “prevalence”

1,223 studies in the library carry the topic tag “prevalence”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,223 tagged studies.

Studies sharing this one's topic tags

Similar studies

More on Health systems and care delivery

See all studies in Health systems and care delivery →